Search Within

Martin Stuart Tallman

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Meeting Abstract (44)
  2. Journal Article (41)
  3. Research Letter (3)
Groups
  1. Adult Leukemia (88)
  2. Center for Hematologic Malignancies (88)
  3. Department of Medicine (88)
  4. Department of Pathology and Laboratory Medicine (88)
  5. Hematologic Malignancies, Division of (88)
  6. GSK Faculty (63)

More Groups

People
  1. Ross Levine (54)
  2. Yanming Zhang (33)
  3. Maria Arcila (31)
  4. Mikhail Roshal (31)
  5. Christopher Famulare (27)
  6. Eytan Stein (27)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (3)
  4. 2022 (5)
  5. 2021 (8)
  6. 2020 (18)

More Years

Publications
  1. Blood (41)
  2. Blood Advances (8)
  3. Haematologica (5)
  4. American Journal of Hematology (3)
  5. Biology of Blood and Marrow Transplantation (3)
  6. Cancer Research (3)

More Publications

Publishers
  1. American Society of Hematology (49)
  2. Nature Publishing Group (8)
  3. American Association for Cancer Research (5)
  4. Ferrata Storti Foundation (5)
  5. Elsevier Inc. (3)
  6. Elsevier Ltd (3)

More Publishers

Results (88)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A comprehensive clinical next generation sequencing-based assay can impact hematopathologic diagnosis in a significant subset of patients with hematologic malignancies
    Meeting Abstract

    Pichardo, J. D.; Feldstein, J. T.; Arcila, M.; Batlevi, C.; Zelenetz, A. D.; Moskowitz, C. H.; Horwitz, S. M.; Tallman, M. S.; Stein, E. M.; Klimek, V. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Vemurafenib has potent antitumor activity in patients with relapsed/refractory BRAF mutant hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Kim, E.; Saven, A.; Wadleigh, M.; Stone, R. M.; Barrientos, J. C.; Rai, K. R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Genomic analysis of serial samples from CLL patients identifies clonal events associated with disease progression
    Meeting Abstract

    Gardner, J. R.; Nahas, M.; He, J.; Aumann, S.; Gonen, M.; Patel, M.; Knapp, K. M.; Palomba, M. L.; Yelensky, R.; Donahue, A. L.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Utility of combined DNA and RNA next generation sequencing in leukemias for identification of prognostic and therapeutically relevant genomic alterations in clinical practice
    Meeting Abstract

    Coombs, C. C.; Viny, A. D.; He, J.; Kobos, R.; Lipson, D.; Shukla, N.; Knapp, K. M.; Otto, G.; Abdel-Wahab, O.; Stein, E. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Brafv600e mutations in hematopoietic stem cells of hairy cell leukemia patients suggests a stem cell origin
    Meeting Abstract

    Chung, S. S.; Kim, E.; Park, J. H.; Chung, Y. R.; Feldstein, J.; Hu, W.; Rampal, R.; Patel, M.; Kim, M. K.; Huberman, K.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia
    Journal Article

    Chung, S. S.; Kim, E.; Park, J. H.; Chung, Y. R.; Lito, P.; Teruya-Feldstein, J.; Hu, W.; Béguelin, W.; Monette, S.; Duy, C.; more...
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • Phase II trial of the BRAF inhibitor, vemurafenib, in patients with BRAF mutant relapsed or refractory hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Teruya-Feldstein, J.; Berger, M.; Khawaja, T. T.; Lacouture, M. E.; Levine, R. L.; Abdel-Wahab, O.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Extensive high-depth sequencing of longitudinal CLL samples identifies frequent mutations in MAP kinase signaling and novel mutations activating notch and beta-catenin
    Meeting Abstract

    Gardner, J. R.; Nahas, M. K.; He, J.; Patel, M.; Knapp, K. M.; Palomba, M. L.; Yelensky, R.; Donahue, A. L.; Otto, G. A.; Arcila, M.; more...
    Blood (2013)

    Fulltext@MSK | Save